Moneycontrol.comBiocon, Amylin Pharma tie up to develop new diabetes drugMoneycontrol.comBiocon will conduct research, trials and manufacture of the potential drug based on Amylin's 'phybrid' or peptide hybrid technology: the Amylin technology ...Biocon, US firm to jointly make drug for diabetesBombay NewsBiocon & Amylin Pharmaceuticals Join Hands For Anti-Diabetes Drugindia-server.comBiocon Seals Development, Commercialisation Agreement With AmylinPharmaceutical Business Reviewall 56 news articles »